StockData
Alkermes plc. logo

Alkermes plc. (ALKS) stock

ALKSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30215% above fair value
$46.53−0.50 (-1.06%)

Close on Nov 16, 2026Market cap $7.81BP/E 122.4Yield –

Alkermes total assets

Total assets on the balance sheet at the end of each period.

Alkermes's total assets was $4.39B at Jun 30, 2026. For fiscal 2025 it was $2.49B, up 21.0% from the year before. Over ten years it grew 3.0% a year on average. The highest annual figure on record is $2.49B in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.49B+21.0%
FY2024Dec 31, 2024$2.06B-3.8%
FY2023Dec 31, 2023$2.14B+8.8%
FY2022Dec 31, 2022$1.96B-3.0%
FY2021Dec 31, 2021$2.02B+3.8%
FY2020Dec 31, 2020$1.95B+8.0%
FY2019Dec 31, 2019$1.81B-1.1%
FY2018Dec 31, 2018$1.83B+1.5%
FY2017Dec 31, 2017$1.80B+4.1%
FY2016Dec 31, 2016$1.73B-7.0%
FY2015Dec 31, 2015$1.86B+26.2%
FY2013Mar 31, 2013$1.47B+2.4%
FY2012Mar 31, 2012$1.44B+217.2%
FY2011Mar 31, 2011$452.45M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$4.39B+95.0%
Q1 FY2026Mar 31, 2026$4.26B+104.5%
Q4 FY2025Dec 31, 2025$2.49B+21.0%
Q3 FY2025Sep 30, 2025$2.33B+8.1%
Q2 FY2025Jun 30, 2025$2.25B+2.1%
Q1 FY2025Mar 31, 2025$2.08B-2.0%
Q4 FY2024Dec 31, 2024$2.06B-3.8%
Q3 FY2024Sep 30, 2024$2.16B-5.4%
Q2 FY2024Jun 30, 2024$2.21B+0.9%
Q1 FY2024Mar 31, 2024$2.12B+10.5%
Q4 FY2023Dec 31, 2023$2.14B+8.8%
Q3 FY2023Sep 30, 2023$2.28B+17.4%
Q2 FY2023Jun 30, 2023$2.19B+11.7%
Q1 FY2023Mar 31, 2023$1.92B-2.8%
Q4 FY2022Dec 31, 2022$1.96B-3.0%
Q3 FY2022Sep 30, 2022$1.94B-2.7%
Q2 FY2022Jun 30, 2022$1.96B+1.0%
Q1 FY2022Mar 31, 2022$1.98B+5.3%
Q4 FY2021Dec 31, 2021$2.02B+3.8%
Q3 FY2021Sep 30, 2021$2.00B+6.3%
Q2 FY2021Jun 30, 2021$1.94B+7.5%
Q1 FY2021Mar 31, 2021$1.88B+2.9%
Q4 FY2020Dec 31, 2020$1.95B+8.0%
Q3 FY2020Sep 30, 2020$1.88B+6.8%
Q2 FY2020Jun 30, 2020$1.80B+2.9%
Q1 FY2020Mar 31, 2020$1.83B+4.0%
Q4 FY2019Dec 31, 2019$1.81B-1.1%
Q3 FY2019Sep 30, 2019$1.76B-0.2%
Q2 FY2019Jun 30, 2019$1.75B+0.0%
Q1 FY2019Mar 31, 2019$1.76B+1.2%
Q4 FY2018Dec 31, 2018$1.83B+1.5%
Q3 FY2018Sep 30, 2018$1.76B+0.7%
Q2 FY2018Jun 30, 2018$1.75B+1.2%
Q1 FY2018Mar 31, 2018$1.74B+0.4%
Q4 FY2017Dec 31, 2017$1.80B+4.1%
Q3 FY2017Sep 30, 2017$1.75B+2.4%
Q2 FY2017Jun 30, 2017$1.73B–
Q1 FY2017Mar 31, 2017$1.73B–
Q4 FY2016Dec 31, 2016$1.73B–
Q3 FY2016Sep 30, 2016$1.71B–

More Alkermes figures

See a number that looks wrong?